Boston Keratoprosthesis type 1 (KPro) without contact lens wearing in end-stage corneal disease: The APEC experience

CONCLUSIONS: We report the results of a retrospective cohort of twenty-three eyes (22 patients) who were implanted with a Boston type 1 KPro without contact lens wearing to treat corneal blindness. BSCVA improved significantly in most patients achieving 20/200 or better at the 2-year follow-up. Retention rate was 87%, with the presence of RPM as the most common complication.PMID:38099653 | DOI:10.1177/11206721231214076

Source: European Journal of Ophthalmology - December 15, 2023 Category: Opthalmology Authors: Guillermo De Wit-Carter C ésar Hernández-Chavarría Pedro-Ivan Navarro-Naranjo Cristal Manzanillo-Rosario Ricardo Navarro-Saucedo Ana Mercedes Garc ía-Albisua Everardo Hernandez-Quintela Emmanuel Cabrera-Mart ínez Gabriela Ordo ñez-Ranz Valeria Sanch Source Type: research